An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial

An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial

<p><strong>Background</strong> There is no vaccine against the major global pathogen <i>Chlamydia trachomatis</i>; its different serovars cause trachoma in the eye or chlamydia in the genital tract. We did a clinical trial administering CTH522, a recombinant version of...

Full description

Bibliographic Details
Main Authors: Pollock, KM, Borges, AH, Cheeseman, HM, Rosenkrands, I, Schmidt, KL, Søndergaard, RE, Day, S, Evans, A, McFarlane, LR, Joypooranachandran, J, Amini, F, Skallerup, P, Dohn, RB, Jensen, CG, Olsen, AW, Bang, P, Cole, T, Schronce, J, Lemm, N-M, Kristiansen, MP, Andersen, PL, Dietrich, J, Shattock, RJ, Follmann, F
Format: Journal article
Language:English
Published: Elsevier 2024

Similar Items